Business Description
Rapport Therapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US75383L1026
Description
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 194.22 | |||||
| Equity-to-Asset | 0.98 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate Estimate | -35.49 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 22.56 | |||||
| 9-Day RSI | 24.6 | |||||
| 14-Day RSI | 27.98 | |||||
| 3-1 Month Momentum % | -32.01 | |||||
| 6-1 Month Momentum % | -27.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 45.91 | |||||
| Quick Ratio | 45.91 | |||||
| Cash Ratio | 45.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -33.98 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -48.32 | |||||
| ROA % | -27.66 | |||||
| ROIC % | -876.4 | |||||
| ROC (Joel Greenblatt) % | -1477.19 | |||||
| ROCE % | -29.02 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.44 | |||||
| Price-to-Tangible-Book | 1.44 | |||||
| EV-to-EBIT | -1.99 | |||||
| EV-to-EBITDA | -2.01 | |||||
| EV-to-FCF | -2.26 | |||||
| Price-to-Net-Current-Asset-Value | 1.46 | |||||
| Price-to-Net-Cash | 1.48 | |||||
| Earnings Yield (Greenblatt) % | -50.25 | |||||
| FCF Yield % | -13.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RAPP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rapport Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.522 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 27.98 | ||
| 14-Day ATR ($) | 1.578407 | ||
| 20-Day SMA ($) | 16.80675 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 12.0948 - 29.74 | ||
| Shares Outstanding (Mil) | 36.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rapport Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rapport Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rapport Therapeutics Inc Frequently Asked Questions
What is Rapport Therapeutics Inc(RAPP)'s stock price today?
The current price of RAPP is $12.69. The 52 week high of RAPP is $29.74 and 52 week low is $12.09.
When is next earnings date of Rapport Therapeutics Inc(RAPP)?
The next earnings date of Rapport Therapeutics Inc(RAPP) is 2025-02-28 Est..
Does Rapport Therapeutics Inc(RAPP) pay dividends? If so, how much?
Rapport Therapeutics Inc(RAPP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers